Geron Corp. (GERN)
1.31
-0.04
(-2.96%)
USD |
NASDAQ |
Jan 15, 11:10
Geron SG&A Expense (TTM): 160.96M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Cassava Sciences, Inc. | 68.06M |
| SELLAS Life Sciences Group, Inc. | 11.21M |
| Rezolute, Inc. | 20.85M |
| GT Biopharma, Inc. | 6.564M |
| Ultragenyx Pharmaceutical, Inc. | 343.56M |